The fourth quarter sell-off hurt big medtech less than big pharma
Some medtech stocks did decline in 2018, but many more increased in value.
2017 saw the stars Align for big-cap medtech
Toothy grins all round at Align, but it is unclear how much longer it can keep up its scorching rate of sales growth.
